UBS Group’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
UBS Group's BCAT Position: Q1 2026 in Review
UBS Group increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 1.9% in Q1 2026, buying an estimated $269K and bringing the position to 978,775 shares worth $13.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2998.
UBS Group first reported a position in BCAT in Q3 2020 and has held it in 23 quarters since. The position peaked at $45.5M in Q4 2021. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- UBS Group held 978,775 shares of BlackRock Capital Allocation Term Trust worth $13.8M as of Q1 2026.
- UBS Group bought 18,274 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $269K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2998 holding.
- UBS Group first reported a position in BlackRock Capital Allocation Term Trust in Q3 2020 and has held it in 23 quarters since.
- UBS Group's BlackRock Capital Allocation Term Trust position peaked at $45.5M in Q4 2021.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.